@prefix adms: <http://www.w3.org/ns/adms#> .
@prefix dcat: <http://www.w3.org/ns/dcat#> .
@prefix dcatap: <http://data.europa.eu/r5r/> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix foaf: <http://xmlns.com/foaf/0.1/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix vcard: <http://www.w3.org/2006/vcard/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://fdp-acc.healthdata.nl/dataset/daecd721-3e26-4699-8d73-f02510a75f52> a dcat:Dataset ;
    dcatap:applicableLegislation <http://data.europa.eu/eli/reg/2025/327/oj> ;
    dct:accessRights <http://publications.europa.eu/resource/authority/access-right/RESTRICTED> ;
    dct:creator [ a foaf:Agent ;
            dct:identifier <https://ror.org/02x6rcb77> ;
            vcard:hasEmail <mailto:wetenschapsbureau@mmc.nl> ;
            foaf:homepage <http://www.mmc.nl> ;
            foaf:name "Máxima Medical Centre" ] ;
    dct:description ""@en,
        "Retrospective Validation of Clinical Decision Support Tools for Predicting Effectiveness Outcomes in Inflammatory Bowel Disease Patients Treated with Vedolizumab: this retrospective study validated two clinical decision support tools (CDSTs) for predicting effectiveness of vedolizumab in IBD patients with real world data from a Dutch hospital. The CDST predicted clinical, composite and steroid-free remission and adherence after 54 weeks well in patients with ulcerative colitis, but not in patients with Crohn's disease. Therefore, the CDST seems especially useful for choice of therapy in ulcerative colitis."@nl ;
    dct:identifier <https://doi.org/10.3390/pharmaceutics18010015> ;
    dct:issued "2026-08-06T13:40:30.554964"^^xsd:dateTime ;
    dct:language <http://id.loc.gov/vocabulary/iso639-1/en> ;
    dct:modified "2026-08-09T02:19:16.174518"^^xsd:dateTime ;
    dct:provenance [ a dct:ProvenanceStatement ;
            rdfs:label ""@en,
                ""@nl ] ;
    dct:publisher [ a foaf:Agent ;
            dct:identifier <https://ror.org/02x6rcb77> ;
            vcard:hasEmail <mailto:wetenschapsbureau@mmc.nl> ;
            foaf:homepage <http://www.mmc.nl> ;
            foaf:name "Máxima Medical Centre" ] ;
    dct:title ""@en,
        "VedPred: Retrospective Validation of Clinical Decision Support Tools for Predicting Effectiveness Outcomes in Inflammatory Bowel Disease Patients Treated with Vedolizumab"@nl ;
    adms:versionNotes ""@en,
        ""@nl ;
    dcat:contactPoint [ a vcard:Kind ;
            vcard:fn "Wetenschapsbureau MMC" ;
            vcard:hasEmail <mailto:wetenschapsbureau@mmc.nl> ] ;
    dcat:keyword "Crohn s disease"@nl,
        "clinical decision support tools  CDSTs  "@nl,
        "colitis ulcerosa"@nl,
        "real world data  RWD "@nl,
        "vedolizumab"@nl ;
    dcat:qualifiedAttribution [ a dcat:Attribution ;
            dcat:agent [ a foaf:Agent,
                        foaf:Organization ;
                    dct:identifier "https://orcid.org/0000-0002-6038-9295" ;
                    foaf:homepage <http://www.mmc.nl> ;
                    foaf:mbox <mailto:l.derijks@mmc.nl> ;
                    foaf:name "Luc Derijks" ] ;
            dcat:hadRole <https://standards.iso.org/iso/19115/resources/Codelists/gml/CI_RoleCode.xml#principalInvestigator> ] ;
    dcat:theme <http://publications.europa.eu/resource/authority/data-theme/HEAL> .

<http://data.europa.eu/eli/reg/2025/327/oj> a <http://data.europa.eu/eli/ontology#LegalResource> .

<http://id.loc.gov/vocabulary/iso639-1/en> a dct:LinguisticSystem .

<http://publications.europa.eu/resource/authority/access-right/RESTRICTED> a dct:RightsStatement .